The Korea Pharmaceutical Manufacturer Association will impose ‘severe disciplinary action’ on companies providing rebates for a large number of drugs with expired patents
Advancing on adoption of ethical management into pharmaceutical companies, the Korea Pharmaceutical Manufacturer Association (KPMA) showed aggressive attitude towards rebates.
While concerns of rebate temptation for a large number of drugs with expired patents have been suggested in the industry...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
